GreenBox
GreenBox POS (NASDAQ:GBOX) ("GreenBox", the "Company"), an innovative blockchain ledger fintech company, today announced that its point-of-sale subsidiary company, ChargeSavvy, recorded the best quarter in its 9-year history, for its retail division during the fourth quarter of 2021. The retail division saw an average increase of 166% demonstrating remarkable growth compared to the same period of 2020. Plus, the board of directors approved a substantial increase in the funds allocated for the immediate repurchase of the company’s common shares, in the initial sum of $10 million. The move comes after the company repurchased approximately 800,000 shares in the second half of 2021. Good news for company and watching for chart, we have a bottom player clearly under accumulation!! A break above its 50 moving average could make it run!! 
Low Floater and highly shorted!! Trade idea is a buy at 5.00 or lower to try a break over 5.65!!
Arcadia Biosciences, Inc.
Analysts who follow Arcadia Biosciences Inc (RKDA) on average expect it to climb 460.75% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. RKDA was granted recently a notice of allowance for a US patent titled 'Wheat Having Resistance to Glyphosate Due to Alterations in 5-Enol-Pyruvylshikimate-3 Phosphate Synthase! RKDA is forming a solid bottom around $1.00, closed at $1.08 on Friday after hours, providing us a nice buy opportunity!!
Engine Gaming and Media, Inc. ("Engine" or the "Company")(NASDAQ:GAME)(TSXV:GAME), an esports/sports social gaming, commerce, and next-generation media solutions company, today announced that Tom Rogers, Executive Chairman of Engine, will participate in a fireside chat hosted by Franco Granda, Research Analyst at D.A. Davidson, at the ICR Virtual Conference 2022. The discussion will take place on Tuesday, January 11, 2022 at 3:00 PM ET. Technically, this setup is a bottom player that showed high relative strength on Friday session! Price is also building a coil break pattern which means, that any break above 3.40 could open the door for a strong upward movement!! Trade idea is a buy at 3.02 or lower!!
Aterian, Inc.
An WallStreet Analyst Rating Rank of 59 gave, last Thursday, a price target for ATER of $22.6 and rate the stock as a Strong Buy. ATER price is trading well bellow its Book/Share, becoming the price very cheap!! Technical indicators on chart are starting to give positive divergences, meaning that buyers are coming back!!Trade idea is a buy at 3.85 or lower to catch a possible squeeze toward $11.00
Insignia Systems, Inc.
ISIG ---> Shares of Insignia haven't made the move that I'm waiting for!! Chart still good, the trend still solid and price seems well controlled by Bulls!! My price target remains intact, which is at least $30.00!! Trade idea is a buy at 23.36 or lower!! Stop loss will be around $18.00
American Virtual Cloud Technologies, Inc.
AVCT ---> AVCT stock had a rough 2021, with shares declining by over 70%. However, this price decline may factor into the recipe for a short squeeze. Total short interest is 4.7 million, which represents a major 3,408% uptick from November’s numbers. In response, the cost to borrow shares of AVCT stock has risen to 191.66%. And this company is on radar of WallStreetBets !!Technically, price is building a nice uptrend, showed high relative strength on Friday, with price closing near of high of the day! Could be setting up for a new breakout!!Trade idea here is a buy at 2.34 or lower to catch the break above $2.85 range and a squeeze toward 4.00!!
Allied Healthcare Products, Inc.
AHPI ---> Price is trading at support level and with states extending the wearing of masks at least until February, AHPI at current price could be a great buy opportunity! Stop bellow 4.88
Orbsat Corp.
Aprea Therapeutics Inc.!!
Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate the mutant tumor suppressor protein, p53, today announced that Christian S. Schade, Chairman and Chief Executive Officer, will present a corporate update at the 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13, 2022 at 11:15 a.m. ET!
This conference may include
✅ Final data from phase 3
✅ Primary results from Apr-548
✅ Update on when FDA hold lift is expected
✅ Further guidance on next step of post maintenance trial and final data
✅ Next step of triplet study, and pre clinical to clinical trial starting guidance
✅ Early phase updates to Keytruda trial.
Shares of Aprea declined more than 50% in last two months!! Any good PR released could send it back to $5.00 range again!! Could be a great opportunity!! Stop loss bellow 2.60
To join on FonsieTrader Headquarters subscribe HERE